serena williams glp 1 ro Inside Williams' partnership with for GLP-1s Serena Williams Lost 31 Pounds

A 2024 study published in JAMA Ophthalmology found that patients prescribed semaglutide had a higher observed risk of NAION compared with patients using non-GLP-1 medications for diabetes or weight loss

More information available on their website Click here for Zepbound.lilly.com

Sleep and obesity

Male C57BL/6 mice (Jackson Laboratories) and male ob/ob mice (B6.Cg-Lep ob

With new clinical trial results expected from a 150-patient, six-month study, Calocurb represents a potent bridge between traditional supplements and pharmaceutical interventions in the weight management space

Figure 2a: From step 1 (left) to steps 2 and 3 (right)